Verified email-pattern data for S-Target Therapeutics is currently limited. You can still use the company insights and contact sections below.
S-TARget therapeutics GmbH is a biotech start-up that develops novel therapeutic vaccines to cure and prevent allergic diseases, based on the unique, proprietary S-TIR™ technology platform. S-TARget‘s vaccines address the cause of the disease not only the symptoms. They are directed against major, widespread severe forms of allergic diseases that currently cannot be cured. Lead candidate SG100 targets allergic asthma induced by house dust mite (HDM), the major cause of allergy in the Western world achieved in vivo proof of concept in the most stringent animal model for house dust mite induced allergic asthma in non-human primates. SG300, targeting birch pollen allergy, showed in vitro proof of concept, using Birch pollen specific T cell clones. Both products are available for outlicensing. S-TARget therapeutics is a privately held company based in Vienna Austria.
The proprietary S-TIR™ technology platform for development of therapeutic vaccines in oncology is outlicensed to OncoQR ML GmbH (www.oncoqr.com). Angothera GmbH (www.angothera.eu) has taken a licence for the use of the S-TIR™ technology platform in animal health
Company Details
- Employees
- 1
- Founded
- -
- Address
- Saarplatz 17, Top 2,austria
- Phone
- 4369918904206
- ge****@****get.com
- Industry
- Biotechnology Research
- Website
- s-target.com
- Keywords
- Human specific vaccines.
- HQ
- Vienna, Vienna
S-Target Therapeutics Questions
S-TARget therapeutics's helpline number is 4369918904206
S-TARget therapeutics's website is s-target.com
S-TARget therapeutics's LinkedIn profile is https://at.linkedin.com/company/s-target-therapeutics
S-TARget therapeutics has
1 employees.
View email and phone details for 1
employees at S-TARget therapeutics.
S-TARget therapeutics's industry is
Biotechnology Research
S-TARget therapeutics's top competitors are
Dioscure Therapeutics,
Mim Pharma,
Oncoqr Ml Gmbh,
Thp Medical Products,
Tridem Bioscience,
Micar Innovation (Micar21.com),
Myelopro Diagnostics And Research Gmbh,
Provectus Pharma Nordic As,
Profem,
The Mannheimer Foundation, Inc..
S-TARget therapeutics's support email address is geert.mudde@s-target.com
S-TARget therapeutics's categories are Biotechnology Research
S-TARget therapeutics's founding year is 2010
Explore related pages
Related company profiles:
Top S-TARget therapeutics Employees
-
Geert C. Mudde
Cso And Founder At Oncoqr Ml, S-Target Therapeutics Gmbh And Tyg Oncology Ltd.
Breitenfurth Bei Wien, Lower Austria, Austria, Austria3s-target.com, oncoqr.com, tyg-oncology.com
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.